Initial validation of the clinical significance of the NETest in Japanese gastroenteropancreatic neuroendocrine tumor patients

Initial validation of the clinical significance of the NETest in Japanese gastroenteropancreatic neuroendocrine tumor patients

As novel biomarkers for gastroenteropancreatic neuroendocrine tumors (GEPNET) are in demand, we aimed to validate the clinical value of the NETest in Japanese patients. Between 2021 and 2023, blood and clinical data were collected from patients with GEPNET. Among 35 patients (median age: 59 [49–66]...

Full description

Saved in:
Bibliographic Details
Main Authors: Hao Zhang, Takahiro Tsuchikawa, Satoshi Takeuchi, Kenji Hirata, Kimitaka Tanaka, Aya Matsui, Yoshitsugu Nakanishi, Toshimichi Asano, Takehiro Noji, Toru Nakamura, Shintaro Takeuchi, Masataka Wada, Satoshi Hirano
Format: Article
Language:English
Published: The Japan Endocrine Society 2024-09-01
Series:Endocrine Journal
Subjects:
gastroenteropancreatic neuroendocrine tumor
netest
japanese population
application value
peptide receptor radionuclide therapy
Online Access:https://www.jstage.jst.go.jp/article/endocrj/71/9/71_EJ24-0090/_html/-char/en
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.jstage.jst.go.jp/article/endocrj/71/9/71_EJ24-0090/_html/-char/en

Similar Items